Rhodiola crenulata has been found to inhibit IL-17 expression and its downstream target genes, thereby improving fibrosis and reducing apoptosis, as well as inhibiting ventricular arrhythmias (92). This evidence concerns the gene IL17A and Ventricular arrhythmia.